Results 101 to 110 of about 47,816 (225)
Biomedical Papers, 2016 Background: Surviving pulmonary embolism (PE) brings a risk of thromboembolic disease chronicity. Chronic thromboembolic pulmonary hypertension (CTEPH) develops as a result of one or multiple pulmonary embolic events.
Zdenek Vavera +4 more
doaj +1 more source
Pulmonary Circulation, 2020 The interventricular septum curvature, measured in images of electrocardiogram-gated 320-slice multidetector computed tomography, is reportedly useful and less invasive than right heart catheterization, as it could provide clues regarding pulmonary ...
Takahiko Saito +8 more
doaj +1 more source
Endothelial cell processing and alternatively spliced transcripts of factor VIII: potential implications for coagulation cascades and pulmonary hypertension. [PDF]
, 2010 BACKGROUND: Coagulation factor VIII (FVIII) deficiency leads to haemophilia A. Conversely, elevated plasma levels are a strong predictor of recurrent venous thromboemboli and pulmonary hypertension phenotypes in which in situ thromboses are implicated ...
Angus, G +9 more
core +1 more source
Chronic thromboembolic pulmonary hypertension
, 2021 This thesis focuses on clinical outcomes of CTEPH patients treated with PH-specific medical therapy or balloon pulmonary angioplasty (BPA). It provides long-term results of medically treated patients, the first results of BPA treatment in the Netherlands and assesses quality of life (QoL) in CTEPH patients.
openaire +2 more sources
Enigma of pulmonary hypertension; echocardiography in the crossroads
Respiratory Medicine Case Reports, 2020 Background: Pulmonary hypertension (PH) with its myriad presentations provides a challenge in its diagnosis and management. Recent WHO classification of pulmonary hypertension as defined at the 5th World Symposium held in Nice, France in 2013 tries to ...
Debasish Roychoudhury +3 more
doaj +1 more source
Review of the British Thoracic Society Winter Meeting 2015, 2-4 December, London, UK [PDF]
, 2016 The British Thoracic Society Winter Meeting 2015 is reviewed in this article. Over 3 days in December, this annual scientific meeting attracted over 2300 delegates and up-to-date respiratory research was presented by leading UK and international speakers.
Chalmers, James D. +3 more
core +2 more sources
British Journal of Pharmacology, EarlyView.Abstract Vascular toxicity is a growing concern in cancer patients receiving vascular endothelial growth factor inhibitor (VEGFi) therapy, posing a significant threat to patient prognosis. While the primary mechanism of VEGFi‐induced vascular toxicity is linked to redox‐sensitive reactions that disrupt vascular tone, leading to hypertension and ...
Grace Whelan, Karla B. Neves
wiley +1 more source
Hormone replacement therapy [PDF]
, 2012 Martha Hickey, Jane Elliott, Sonia Louise ...
Davison, S., Elliott, C., Hickey, M.
core +2 more sources
Cardiotoxicity of BRAF/MEK inhibitors
British Journal of Pharmacology, EarlyView.Abstract Rapidly accelerated fibrosarcoma type B/B‐Raf proto‐oncogene, serine/threonine kinase (BRAF) and mitogen‐activated protein kinase (MEK) inhibitors have transformed outcomes in cancer therapy, particularly in melanoma. However, cardiovascular toxicities are increasingly recognized in real‐world clinical practice.
Katharina Seuthe +4 more
wiley +1 more source
CLINICAL CASE: CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION IN A CHILD
Евразийский Кардиологический Журнал, 2017 The article deals with a rare clinical case of chronic thromboembolic pulmonary hypertension in children. This case demonstrates the difficulty of identifying of chronic thromboembolic pulmonary hypertension and masking it under the community-acquired ...
D. J. Sadykova +5 more
doaj +1 more source